Novel discriminative stimulus effects of TPA023B, subtype-selective γ-aminobutyric-acidA/benzodiazepine modulator: Comparisons with zolpidem, lorazepam, and TPA023-Reference-Cited by-同舟云学术

Novel discriminative stimulus effects of TPA023B, subtype-selective γ-aminobutyric-acidA/benzodiazepine modulator: Comparisons with zolpidem, lorazepam, and TPA023

Published:2008-07 Issue:1 Volume:90 Page:65-73
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Kohut Stephen J.,Ator Nancy A.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference43 articles.

1. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site;Atack;Curr Drug Targets CNS Neurol Disord,2003

2. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluor ophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates;Atack;J Pharmacol Exp Ther,2006

3. Comparison of lorazepam [7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one] occupancy of rat brain γ-aminobutyric acidA receptors measured using in vivo [3H]flumazenil (8-fluoro 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester) binding and [11C]flumazenil micro-positron emission tomography;Atack;J Pharmacol Exp Ther,2007

4. Discriminative stimulus effects of the novel anxiolytic buspirone;Ator;Behav Pharmacol,1991

5. Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons;Ator;Drug Alcohol Depend,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders;Pharmacology Biochemistry and Behavior;2022-02

2. Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5‐Subtype Selective GABA A ‐Positive Allosteric Modulator PF‐06372865 in Healthy Volunteers;Clinical Pharmacology in Drug Development;2021-01-19

3. The α2/α3GABAA receptor modulator TPA023B alleviates not only the sensory but also the tonic affective component of chronic pain in mice;Pain;2020-08-05

4. Further evaluation of the potential anxiolytic activity of imidazo[1,5- a ][1,4]diazepin agents selective for α2/3-containing GABA A receptors;Pharmacology Biochemistry and Behavior;2017-06

5. The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABAA receptors;Psychopharmacology;2014-02-22